Focused ultrasound (FUS) and deep brain stimulation (DBS) solve the same broad problem in fundamentally different ways. FUS uses MRI-guided sound energy to heat a precisely chosen area and leave a permanent lesion. DBS places an electrode and pulse generator that deliver adjustable electrical stimulation. Neither treatment cures Parkinson’s disease or stops its progression, and neither is automatically “better.” The right choice depends on the symptom being treated, target and side intended, levodopa response, cognition, surgical fitness, regulatory indication, and the person’s tolerance for a permanent lesion versus implanted hardware and continuing programming.
The comparison below explains what each procedure can target, how candidacy is assessed, what the U.S. indications actually cover, and which trade-offs to discuss with a movement-disorders team.
As an Amazon Associate I earn from qualifying purchases.
Focused ultrasound and DBS at a glance
| Question | Focused ultrasound | Deep brain stimulation |
|---|---|---|
| What changes in the brain? | MRI-guided ultrasound heats a small target and creates a permanent lesion. | An implanted lead delivers electrical stimulation through a battery-powered pulse generator. |
| Can treatment be adjusted later? | No. The lesion cannot be reprogrammed or removed if symptoms or side effects change. | Yes. Clinicians can change stimulation settings without another brain operation. |
| Is hardware implanted? | No stimulator or brain lead is left in place, although treatment requires specialized MRI-guided equipment. | Yes. Leads, extensions and a pulse generator remain part of ongoing care. |
| Common Parkinson’s targets | Thalamus for tremor; globus pallidus internus (GPi) for pallidotomy; specified pallidothalamic tract targets for some indications; subthalamic nucleus (STN) lesioning is described as experimental in the cited Parkinson’s Foundation material. | Most commonly the STN or GPi, selected according to symptoms, medication response and the clinical plan. |
| What symptoms may improve? | Depends on the lesion target and indication: tremor, stiffness, slowness, dystonia, dyskinesia or medication “off” time may be addressed in selected patients. | Movement symptoms such as tremor, rigidity, bradykinesia, dystonia, dyskinesia and motor fluctuations may improve when they are responsive to levodopa. |
| Main irreversibility | The tissue lesion is permanent; bilateral lesions can carry greater side-effect risk. | The surgical implants are removable, but surgery and hardware complications are real; stimulation itself can be turned down or off. |
| Does it cure Parkinson’s? | No. | No. Most people continue Parkinson’s medication, although some may be able to reduce it. |
This is not a comparison of “non-surgical” and “surgical” treatment in an absolute sense. Focused ultrasound avoids an implanted stimulator but uses a procedure that intentionally damages a small area of brain tissue. DBS requires invasive implantation but preserves the ability to change stimulation over time.
How focused ultrasound works
MRI-guided lesioning
During focused ultrasound, MRI provides images for locating the target and monitoring temperature. Many ultrasound beams pass through the skull and converge on a small spot. Raising the temperature at that spot creates a lesion intended to interrupt abnormal movement circuits. The approach is often described as non-invasive because there is no incision for a lead or generator, but it is still a specialized brain procedure and the resulting lesion is permanent.
#1 Best Overall
- [Ultra-Lightweight Ear Buds Designed for Small Ears] Each earbud weighs only 3.7g and features a compact, ergonomic in-ear design made especially for small ears. Secure, low-profile, and comfortable for workouts, all-day wear or overnight sleeping.The ultra-slim profile sits flush in your ear with no hard edges poking or rubbing, so you can even sleep on your side without discomfort.
- [Immersive Stereo Sound with TOZO OrigX Technology] TOZO OrigX tuning delivers clear vocals, balanced mids, and natural stereo sound for music, podcasts, and videos.
- [Long Battery Life for Daily Use] Get up to 7 hours of playtime on a single charge, with up to 32 hours total using the charging case—ideal for workdays, commuting, and extended listening sessions.
- [Bluetooth 5.3 & Stable Connection] Bluetooth 5.3 provides fast pairing, stable wireless performance, and reduced dropouts as you move around home or office.
- [Deep Bass with Clear Vocals] High-performance drivers produce punchy bass while keeping vocals clean and detailed for everyday listening.
Targets are chosen for a specific symptom goal
- Thalamus (thalamotomy): used to reduce medication-refractory tremor in selected Parkinson’s patients.
- Globus pallidus internus (pallidotomy): may be used for advanced disease with medication-refractory motor complications, including stiffness, slowness, dystonia, tremor, dyskinesia or “off” periods, depending on the indication and clinical assessment.
- Pallidothalamic tract: U.S. device labeling describes a unilateral tractotomy indication for advanced idiopathic Parkinson’s disease with medication-refractory, moderate-to-severe motor complications.
- Subthalamic nucleus: the Parkinson’s Foundation describes subthalamotomy as experimental and not FDA-approved in the context it discusses. Do not assume that an investigational target is covered by a device’s approved indications.
Because a lesion cannot be moved or reprogrammed, the target and side must be selected carefully. A procedure aimed at tremor does not automatically treat balance, cognition, depression, speech, or every other Parkinson’s symptom.
What the treatment experience implies
The center must have the MRI system, ultrasound equipment and expertise to reach the planned target safely through the person’s skull. The treatment does not leave a stimulator to maintain, but it does leave tissue permanently altered. If a new side effect appears later, there is no programming session that can reverse the lesion. Parkinson’s Foundation information notes that some gait or balance problems may improve, while others can persist.
How DBS works
Implanted components
DBS uses a thin lead placed in a movement-related brain target. An extension under the skin connects that lead to a battery-operated pulse generator, usually implanted elsewhere in the body. The generator sends electrical pulses that modulate activity in circuits involved in movement. NINDS identifies the STN and GPi as common Parkinson’s targets.
Free tools Windows power users keep installed
One-click scans. No signup required.
Programming is part of the treatment
After implantation, a clinical team adjusts stimulation settings to balance benefit and side effects. Settings can be changed as symptoms, medication schedules or tolerability change, without repeating the brain operation. This flexibility is DBS’s defining contrast with lesioning, but it also means that follow-up visits, programming and device care remain part of the treatment pathway.
Rank #2
- 【IP68 Waterproof Multifunctinal Smart Watch】Torjalph fitness activity tracker smart watch is IP68 waterproof technology ,you can wear it when swimming,handwashing,it's rain-proof which means that you perform multiple exercise modes outside without worrying about sweat or rain corroding your fitness smart watch,and this watch equipped with a 230 mAh large capacity battery magnetic charging ,and this sports activity tracker watch can be used 5-7 days If fully charged.
- 【Larger 1.83'' Full Screen Watch & Multi-dial Selection】1.83 inch full HD color touch screen smart watch for men / women provides excellent 240*284 resolution image quality ,This Bluetooth smart watch offers a better touch experience and remarkable immersion and ,more than 200 watch faces for you to choose from App"Da Fit ", you can change the dial style according to your mood to wear keeping the world on your wrist
- 【Accurate Activity Tracker Smart Watch 】sports watch activity tracker uses sweat and dust resistant breathable silicone strap, our Fitness Tracker Smart Watch for Android iOS Phones supports 12 sports modes,walking,running,bicycle,swimming,badminton,basketball,football,rope skipping. This bluetooth calls smart watch for men women is lightweight and stylish, bringing more convenient and relaxing sports experience while also providing more protection.
- 【Your 24 Hour Personal Daily Health Monitor】Fitness watch for women men full touch screen IP67 waterproof bluetooth smartwatch for Android iOS Phones with heart rate blood pressure monitor multifunction Andriod smart watch with steps counter sleep monitor sports fitness watch, monitoring blood oxygen saturation allows you to understand your physical condition in real time to track fitness progress ,to know your health status in time.
- 【More Functions Bluetooth Call Smart Watch】This fitness activity smart watch full screen for iPhone and Android phones includes a bunch of new features including:The bluetooth smart watch can hang up the phone, receive and display WhatsAPP /Text /Facebook /Twitter /Messenger reminder.Support sedentary reminder, alarm clock, stopwatch, timer,weather information,music control, remote camera control compatible with Android 5.0 and above or iOS 9.0 and above smartphones.
Medication usually continues
DBS is an adjunct to Parkinson’s treatment, not a replacement for every medication. Most recipients continue medication; some can reduce the dose or smooth out motor fluctuations. The degree of benefit depends on the symptoms, their response to levodopa, target selection and individual factors.
Which symptoms each option is intended to address
Symptoms DBS may help
DBS is generally considered for disabling movement symptoms that remain troublesome despite medication adjustment. Potential targets of treatment include tremor, stiffness, slowness, dystonia, dyskinesia and motor fluctuations. People whose motor symptoms still improve with levodopa often have a better chance of benefiting, although levodopa response is only one part of candidacy.
DBS should not be presented as a reliable treatment for dementia, depression, anxiety, balance problems or speech concerns. Those symptoms require their own assessment and management. Treating a medication-responsive tremor does not guarantee improvement in gait or cognition.
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteSymptoms addressed by focused-ultrasound lesioning
FUS is more target- and indication-specific. A thalamic lesion is intended primarily for tremor. Pallidal or pallidothalamic procedures may be considered for particular combinations of rigidity, bradykinesia, dystonia, tremor, dyskinesia and “off” time in advanced disease. The expected benefit is not identical for every target, and a lesion for one side of the body does not automatically treat the opposite side.
Rank #3
- [Low Noise High Fidelity] New bee guitar cord with 22AWG oxygen-free-copper center conductors provides enhanced signal transfer, the PVC insulation material and the high-density stranded copper double shield provide noise rejection for quiet operation
- [Ideal for Choice] New bee 1/4 straight and right angle metal connectors, ensures a secure connection in any instrument, pedal, or amp jack. L shape great fro on stage guitar stands
- [Wide Compatible] Suitable for mixer, power amplifier, microphone, effector, decoder, equalizer, electoronic organ, electric guitar, electric bass and other electronic equipments. Widely used in the installation of smart home, karaoke speaker, professional stage audio, etc
- [Easy Disassemble] Making incidental repairs quick and easy! Very nice, flexible cable
- [Dont Hesite to Order] 24 hours customer services and professional technology team are standing by
For either procedure, ask the specialist to name the symptom being targeted and to identify symptoms that are unlikely to change. This prevents a successful tremor treatment from being judged as a failure because balance or speech remains unchanged.
What U.S. FDA indications do—and do not—mean for focused ultrasound
FDA records for the Exablate Neuro MR-guided focused-ultrasound system describe several Parkinson’s indications, each with its own disease stage, symptom severity, medication refractoriness, target and laterality:
- Unilateral thalamotomy for medication-refractory, tremor-dominant Parkinson’s disease.
- Unilateral pallidotomy for advanced idiopathic Parkinson’s disease with medication-refractory, moderate-to-severe motor complications, as an adjunct to medication.
- Unilateral pallidothalamic tractotomy for advanced idiopathic Parkinson’s disease with medication-refractory, moderate-to-severe motor complications.
- A staged contralateral pallidothalamic tractotomy for qualifying opposite-side symptoms, performed at least six months after the first procedure in the specific device supplement.
“At least six months” is a labeled minimum interval for that staged contralateral procedure, not a general statistic about safety or a rule for every focused-ultrasound target. FDA authorization for one device and indication is not blanket approval for every lesion target, bilateral treatment or research protocol. A center must determine whether the current label, the person’s anatomy and the proposed symptom goal align.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minuteWho may be considered for DBS
Clinical factors
The Parkinson’s Foundation lists considerations that commonly enter a DBS evaluation:
Rank #4
- Digital Family Calendar: BSIMB digital calendar wall touch screen puts an end to your chaotic life. Designed for busy families, the digital calendar keeps you organised and in step with your family. Assign different colours and tasks to each family member to make family scheduling easier and more intuitive.
- Easy Setup and Auto-Sync: Plug in, connect to WLAN and auto-syn your electric calendar in minutes. Digital wall calendar compatible with Google calendar, iCloud calendar, Outlook calendar, Cozi calendar and Yahoo calendar. Add events directly on the device or through the ecalendar app. Electronic calendar stays current whether you're at work or traveling—no manual updates needed.
- All-In-One Home Assistant: Smart calendar builds habits and encourage independence with personalised chores. Display daily meal plan to reduce the daily ‘What's for dinner?’ stress. To-do lists keep track of everything you want. Turning chores into valuable achievements with stars and rewards, making life easier and more enjoyable.
- Manage Anytime Anywhere: BSIMB electronic calendar for family stay connected with the powerful ecalendar app. Access and manage your digital wall calendar anytime, anywhere with free features like stars & rewards, photo screensaver, chore charts, meals plans, to-do lists etc. Electronic planner paid features like Magic Import tailor advanced tools for users with special needs.
- Stay in Touch with Loved Ones: Share photos or videos from your phone to electronic wall calendar with app, instantly update your life moment, and keep in touch with your family, especially those who are far away; you can also surprise your smart calendar digital wall by sending him a wish card; it's also great for keeping tech-illiterate elders in touch with the youngsters.
- A confirmed Parkinson’s diagnosis rather than a condition unlikely to respond to DBS.
- Disabling tremor, dyskinesia or severe motor fluctuations despite reasonable medication adjustment.
- Motor symptoms that continue to respond to levodopa, which helps predict which features may respond to stimulation.
- Ability to tolerate the operation and the longer-term follow-up required for programming and device care.
- No severe cognitive impairment; significant cognitive or psychiatric problems can change the risk–benefit balance.
These are considerations, not a universal checklist. A movement-disorders neurologist should review the diagnosis, medication response, motor diary, imaging and other medical conditions. Neuropsychological testing is strongly recommended by the Parkinson’s Foundation because memory, executive function, mood and coping ability affect both safety and the practical demands of DBS.
Why levodopa response matters
If slowness, rigidity or tremor reliably improve during a levodopa response test, those same motor features are more likely to be candidates for DBS benefit. Symptoms that do not respond to levodopa are less predictable. This does not mean a person must have perfect medication response or that every levodopa-responsive symptom will improve; it is one piece of a multidisciplinary decision.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Who may be considered for focused ultrasound
Focused-ultrasound candidacy must be matched to the specific FDA indication or, where applicable, a clinical study. The specialist will consider whether the person has the disease type and severity named in the label, whether the target corresponds to the disabling symptom, whether medication has failed to provide adequate control, and whether the proposed side and staged-treatment plan are appropriate.
An imaging and treatment center must also decide whether the target can be reached safely through the skull and whether the person can tolerate the MRI-guided procedure. The existence of an approved indication does not predict eligibility for a particular individual, and availability, reimbursement and local practice can change. Ask the center to identify the exact device indication being used rather than relying on the broad phrase “focused ultrasound for Parkinson’s.”
Trade-offs that usually matter in the decision
| Decision axis | Focused ultrasound | DBS |
|---|---|---|
| Reversibility and flexibility | Permanent lesion; no later programming can undo an unwanted effect. | Stimulation can be adjusted, reduced or turned off; changing the lead position still requires surgery. |
| Implant burden | No implanted stimulator, lead or generator. | Implanted lead, extension and pulse generator require ongoing care and eventual battery management. |
| Procedure type | MRI-guided thermal lesioning with specialized equipment. | Invasive neurosurgery to implant the lead and generator. |
| Laterality | Lesion side is permanent; bilateral lesioning can increase side-effect risk. The cited FDA tractotomy supplement specifies at least six months before the staged opposite-side procedure. | One or both sides may be stimulated, with settings adjusted over time; candidacy remains individual. |
| Follow-up | No stimulator programming, but follow-up is needed to assess benefit and persistent or delayed effects. | Programming visits, medication adjustments and device follow-up are integral to care. |
| Evidence comparison | The cited authoritative material does not establish a direct head-to-head efficacy or complication-rate advantage. Do not infer that one is safer or more effective for everyone. | |
Risks and limitations
Focused-ultrasound risks
Reported possible effects include headache, dizziness, nausea, balance or walking problems, numbness or tingling, weakness, and speech or swallowing problems. Rare serious risks include stroke and seizure. Some gait or balance problems resolve; others may persist. Because the lesion is permanent, an adverse effect cannot be corrected by changing a device setting. Treating both sides can carry greater side-effect risk than treating one side.
DBS risks
DBS requires brain surgery. NINDS describes risks including bleeding or infection in the brain, headache, seizures and temporary postsurgical pain. Stimulation can affect tissue near the target and may produce unwanted effects that require programming changes or, in some cases, additional medical or surgical management. The implanted system introduces device-related care and complications in addition to the initial operation.
What neither procedure fixes
Neither DBS nor FUS stops neurodegeneration or guarantees protection from future Parkinson’s symptoms. Non-motor problems such as dementia, depression, anxiety, balance impairment and speech difficulties may remain or progress even when a targeted movement symptom improves. Medication, rehabilitation, speech therapy and other care may still be needed.
A practical decision process
- Define the disabling problem. Record which symptoms limit walking, work, sleep, independence or medication timing. Separate tremor from dyskinesia, “off” periods, stiffness, slowness, balance and non-motor symptoms.
- Document medication response. Ask the neurologist which symptoms improve with levodopa and which do not. This information is especially important for DBS planning.
- Obtain a specialist evaluation. Use a movement-disorders neurologist and, for DBS, a team experienced in surgical treatment. Expect neurological, medication, imaging and cognitive or neuropsychological assessment.
- Match symptom, target and side. Ask whether the proposal is thalamic, pallidal, pallidothalamic, STN or another target, and why that target fits the symptom. Clarify whether one side or a staged bilateral approach is being considered.
- Check the regulatory indication. For focused ultrasound, request the exact current device indication and confirm that the disease stage, medication-refractory status, target and laterality fit it. Do not treat an experimental target as an approved one.
- Compare permanence with adjustability. Decide how you value an incision-free treatment without implanted hardware against the permanence of a lesion, or how you value DBS’s programmability against implantation and ongoing device care.
- Plan for limitations and follow-up. Ask which symptoms are unlikely to improve, how side effects will be handled, who performs programming or follow-up, and what medication changes are realistic.
Questions to take to the movement-disorders team
- Which single symptom or symptom cluster is this procedure intended to improve?
- Which of my symptoms are unlikely to improve, including balance, speech, mood or cognition?
- What target and laterality do you recommend, and what evidence supports that choice for my pattern of symptoms?
- How does my levodopa response affect the expected DBS benefit?
- What cognitive, psychiatric or medical findings would make DBS or focused ultrasound a poor fit?
- For focused ultrasound, which current FDA indication applies, and is the proposed target unilateral or part of a staged plan?
- For DBS, who will program the device, how often will follow-up occur, and how will medication and stimulation be coordinated?
- What is the plan if the treatment does not help, or if a side effect persists?
- What local availability, insurance authorization and travel requirements should be confirmed before scheduling?
Bottom line
Focused ultrasound is a one-time, MRI-guided lesion that avoids implanted hardware but permanently changes a selected brain target. DBS is an implanted, adjustable stimulation system that offers reversibility in its settings but requires invasive surgery and continuing device management. The clinically important question is not which technology wins in general; it is which target and treatment pathway best fit the person’s medication-responsive symptoms, cognitive and medical profile, desired laterality, tolerance for permanence, and the indication available at an experienced center. A qualified Parkinson’s team should make that determination with the patient.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
